Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Preparedness and response against diseases with epidemic potential in the European Union: A qualitative case study of Middle East Respiratory Syndrome (MERS) and poliomyelitis in five member states
Kinsman, J., Angrén, J., Elgh, F., Furberg, M., Mosquera, P.A., Otero-García, L., Snacken, R., Derrough, T., Carrillo Santisteve, P., Ciotti, M., Tsolova, S.
Respiratory tract infections - Annual epidemiological report for 2012-13
The Annual Epidemiological Report 2014 gives an overview of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union and European Economic Area countries. The respiratory tract infections chapter from the upcoming ECDC Annual Epidemiological Report 2014 is now available as a separate report and provides a snapshot of the epidemiological situation in Europe across a number of diseases.